1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6AD93D0D54B13050B002588B800200973
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-hybrid-work-models-commercial-biopharma-organizations-model-types-staffing?opendocument
18
19opendocument
203.223.3.251
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Marketing Management » Marketing Strategy

Hybrid Work Models for Commercial Biopharma Organizations: Model Types and Staffing

ID: 5733


Features:

5 Info Graphics

20 Data Graphics

330+ Metrics


Pages/Slides: 32


Published: 2022


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Hybrid Work Models for Commercial Biopharma Organizations: Model Types and Staffing”

STUDY OVERVIEW

With the pandemic now reaching a waning stage in most parts of the world, Commercial leaders must decide what is the right hybrid model for their organization: continue to work remotely, return to all in-person, or develop a flexible hybrid approach?

Best Practices, LLC undertook this benchmarking research to examine the changing forms, features, conditions, and triggers for hybrid work models that are best suited for a flexible and resilient Commercial function.

The study probes and profiles how different Commercial organizations are shifting and shaping staff roles, adjusting remote vs. in-person work schedules, and planning post-pandemic.

Few of the benchmark insights are further segmented by company size to provide deeper insights: Large companies vs. Mid-small companies.

KEY TOPICS

  • Types of Commercial Work Models
  • Activities and Staffing in Successful Hybrid Models

KEY METRICS

  • How much time the staff of each Commercial group spends in each work venue (remote, company office, customer site / in field) during and post-pandemic?
  • At what level are "work from home" decisions typically made for each kind of commercial employee?
  • Are commercial team leaders expected to spend more time in the office than frontline staff and team members?
  • Please rate the listed commercial work activities in terms of their suitability to be conducted in a virtual work environment where people connect remotely
  • Which commercial activities have proven especially well-suited or poorly suited for being executed in a hybrid or virtual manner?
  • Approximately what turnover rate has been experienced within different parts of the Commercial organization over the last two years?
  • How effective have the listed tactics proven in evolving staffing needs to reflect the hybrid work environment of the workforce?
  • What factors are most influential in establishing the continuation of at least partial remote work?
  • Please describe any changes to the qualifications / experiences sought when hiring employees who will work in a hybrid model

SAMPLE KEY FINDINGS

  • Where work gets done: On average, field sales and launch will spend slightly more time in office. Market access, marketing and sales management will spend more time remotely.

METHODOLOGY

Best Practices, LLC engaged 23 Commercial leaders from 20 pharma companies in this research through a benchmarking survey.

Industries Profiled:
Health Care; Biotech; Medical Device; Pharmaceutical; Consumer Products; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
AccelRx; ADC Therapeutics; Aesculap; AstraZeneca; BELLUS Health; Boehringer Ingelheim; Cardinal Health; CSL Behring; DePuy Synthes; Janssen; Kaléo; Klosterfrau Healthcare Group; Novartis; Optum Specialty Pharmacy; Sanofi; Sanofi Genzyme; Servier; Sobi; Takeda Pharmaceuticals; Tris Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.